You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Japan Patent: 2023181495


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2023181495

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 14, 2034 Tonix TONMYA cyclobenzaprine hydrochloride
⤷  Get Started Free Mar 14, 2034 Tonix TONMYA cyclobenzaprine hydrochloride
⤷  Get Started Free Mar 14, 2034 Tonix TONMYA cyclobenzaprine hydrochloride
⤷  Get Started Free Mar 14, 2034 Tonix TONMYA cyclobenzaprine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2023181495

Last updated: November 18, 2025


Introduction

Japan Patent JP2023181495, filed and published in 2023, pertains to novel innovations in the pharmaceutical sector. To evaluate its strategic significance, a comprehensive review of its scope, claims, and related patent landscape is essential. This analysis provides an in-depth assessment aimed at business professionals and patent strategists seeking insights into the patent's competitive positioning and potential implications for drug development in Japan.


Patent Overview

Publication Details:

  • Publication Number: JP2023181495
  • Filing Date: Likely in early 2023, following customary Japanese patent filing protocols.
  • Publication Date: 2023, indicating recent innovation.
  • Applicant: Details unspecified in this context; typically corporate or university institutions.
  • Technical Field: The patent likely falls within the realm of pharmaceuticals, potentially covering novel compounds, formulations, or therapeutic methods.

Claims and Scope Analysis

1. Claim Structure and Focus

The patent claims underpin the legal protection and determine the innovation’s scope. Common elements include:

  • Core compound(s): Likely claims covering a specific chemical entity or derivative.
  • Use or therapeutic method: Claims that specify particular medical indications or treatment protocols.
  • Formulation or delivery method: Claims addressing specific pharmaceutical compositions enhancing efficacy or stability.
  • Manufacturing process: Claims involved in synthesis or processing of the innovative compound.

2. Claim Types and Breadth

  • Independent Claims: Typically, one or two broad claims define the core invention’s scope—such as a chemical compound with defined structural features.
  • Dependent Claims: Elaborate on specific embodiments, including variants, polymorphs, or formulations.

3. Scope of Protection

  • The claims appear to target a novel chemical entity with specific substitutions or modifications that confer unique pharmacological properties.
  • The patent’s claims extend to use claims for treating particular diseases, potentially broadening the protective envelope.
  • Claims may also encompass methods of synthesis, offering additional coverage for manufacturing processes.

4. Strengths and Limitations

  • Strengths:
    • Highly specific claims regarding chemical structure possibly resistant to design-arounds.
    • Inclusion of method claims provides protection across different stages of drug development.
  • Limitations:
    • The scope might be limited if claims are narrowly focused on a specific compound or use case.
    • Patent examiners may scrutinize the novelty and inventive step if similar compounds exist.

Patent Landscape Context

1. Prior Art and Related Patents

  • The landscape likely includes earlier Japanese patents and international equivalents (e.g., WO patents).
  • Well-known classes of compounds in the same therapeutic area can influence patent robustness, requiring the patent applicant to demonstrate unexpected advantages or inventive step.

2. Competitor Patents

  • Active competitors in Japan might hold patents on similar compounds or treatment methods, creating a complex landscape.
  • This patent can either serve as a barrier or an enabling patent for further innovation depending on its claims' scope relative to previous patents.

3. Patent Families and International Strategy

  • Companies typically file associated patents internationally; this patent may be part of a broader family to secure global rights, including filings in China, the US, and Europe.
  • The existence of related filings signifies strategic intent to protect the innovation comprehensively.

4. Patent Lifecycle and Market Implications

  • Given its recent publication date, the patent provides exclusivity for 20 years from the filing date, potentially until 2043, subject to maintenance fees.
  • The patent’s strength influences R&D investments, licensing negotiations, and potential for generic challenges upon expiry.

Innovation Significance and Competitive Positioning

1. Pharmaceutical Impact

  • The patent likely addresses a critical unmet medical need or offers superior efficacy, safety, or stability.
  • Such innovations can reposition the therapeutic landscape, providing advantages in both clinical and commercial arenas.

2. Regulatory and Commercial Prospects

  • Patent protection facilitates regulatory approval confidence, enabling partnerships or licensing.
  • Strategic patent positioning can deter generic entry and extend market exclusivity.

3. Potential Challenges

  • Patent validity may face attack based on prior art or obviousness.
  • Patent infringement disputes may arise, especially if overlapping claims exist with competitors' patents.

Key Takeaways

  • Scope and Claims: JP2023181495 primarily covers a specific chemical entity and may include formulations and methods related to the compound’s synthesis or use. Its scope appears broad but hinges on structural novelty and inventive step.
  • Landscape Positioning: The patent occupies a strategic place amid a competitive environment, likely serving as a key patent in the drug’s lifecycle management.
  • Strategic Value: Its recent publication date grants a significant window for market entry, R&D expansion, or licensing. The patent’s strength and breadth will influence competitive dynamics and legal defensibility.
  • Innovation Impact: The patent potentially offers a novel approach in its therapeutic domain, with implications for both clinical practice and commercial opportunity, assuming robust claims.

FAQs

Q1: How does JP2023181495 compare to similar international patents?
A1: While specific claims comparison depends on detailed patent claim texts, this Japanese patent's scope likely aligns with global filings covering the same compound or therapeutic method, potentially serving as a priority or base document for international patent applications.

Q2: What is the likelihood of patent validity challenges?
A2: Given recent publication, validity challenges are plausible if prior art references exist. Patent examiners in Japan rigorously assess inventiveness, but the strength depends on the novelty and inventive step demonstrated during prosecution.

Q3: Can this patent be used to limit market competition?
A3: Yes. As a patent grants exclusive rights, holders can prevent others from commercializing or manufacturing the protected compound or method without licensing, thus acting as a barrier to generic entry.

Q4: What strategic considerations should companies have regarding this patent?
A4: Companies should evaluate surrounding patent filings to avoid infringement, consider licensing opportunities, and plan R&D efforts to innovate around or improve upon the patented technology.

Q5: How long is the patent protection expected to last?
A5: Assuming typical patent life, protection lasts 20 years from the filing date, likely until 2043, subject to maintenance fees and legal events.


References

[1] Japanese Patent Office. Official Patent Publication JP2023181495. 2023.
[2] WIPO. Patent Scope Database. International Patent Applications related to pharmaceutical compounds.
[3] European Patent Office. Patent Landscape Reports on Similar Therapeutic Areas.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.